sotorasib 240 MG Oral Tablet [Lumakras]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

sotorasib 240 MG Oral Tablet [Lumakras]

240 MG · Oral Tablet · oral

A form of sotorasib →

sotorasib 240 MG Oral Tablet [Lumakras] — Other antineoplastic agents. Strength, form, class, interactions & more.

sotorasib 240 MG Oral Tablet [Lumakras]

Active ingredient

Classification

Other antineoplastic agents

Drug interactions

Sotorasib has several drug interactions that may affect its efficacy and the safety of coadministered medications.

  • majorproton pump inhibitors (PPIs) — decreased sotorasib concentrations
  • majorH 2 receptor antagonists — decreased sotorasib concentrations
  • majorstrong CYP3A4 inducers — decreased sotorasib concentrations
  • majorCYP3A4 substrates — decreased plasma concentrations of the substrate
  • majorP-gp substrates — increased plasma concentrations of the substrate
  • majorBCRP substrates — increased plasma concentrations of the substrate

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.